24.9 C
New York
Tuesday, June 6, 2023

Is Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) The Best Stock To Invest In?

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Vanda Pharmaceuticals Inc. (VNDA) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.53, or -8.29%, to $5.86. The Vanda Pharmaceuticals Inc. has recorded 45,595 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Vanda Pharmaceuticals Reports First Quarter 2023 Financial Results.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

Vanda Pharmaceuticals Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $6.39 and fluctuated between $6.45 as its day high and $6.28 as its day low. The current market capitalization of Vanda Pharmaceuticals Inc. is $366.47M. A total of 0.57 million shares were traded on the day, compared to an average of 578.98K shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, VNDA has seen 6 BUY and 10 SELL insider trades, representing the acquisition of 272,208 and the disposition of 104,246 shares. Over the last 12 months, there were 16 BUYs and 21 SELLs from insiders. Insiders purchased 508,982 shares during that period but sold 242,723.

In the most recent transaction, Polymeropoulos Mihael Hristos sold 22,538 shares of VNDA for 6.25 per share on Mar 03. After the transaction, the President and CEO now owns 1,476,902 company shares. In a previous transaction on Mar 03, Williams Timothy sold 8,301 shares at 6.25 per share. VNDA shares that SVP & General Counsel owns now total 103,513.

Among the insiders who sold shares, Birznieks Gunther disposed of 8,268 shares on Mar 03 at a per-share price of $6.26. This resulted in the SVP, Business Development holding 205,980 shares of VNDA after the transaction. In another insider transaction, Moran Kevin Patrick sold 5,968 shares at $6.28 per share on Mar 03. Company shares held by the SVP, CFO & Treasurer now total 138,926.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for VNDA in the last 3 months, the mean price target is $7.00 with high estimates of $7.00 and low estimates of $7.00. In terms of 52-week highs and lows, VNDA has a high of $11.90 and a low of $6.05.

As of this writing, VNDA has an earnings estimate of $0 per share for the current quarter. EPS was calculated based on a consensus of 0 estimates, with a high estimate of $0 per share and a lower estimate of $0. The company reported an EPS of $0.06 in the last quarter, which was -33.30% lower than expectations of $0.09.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. VNDA’s latest balance sheet shows that the firm has $432.81M in Cash & Short Term Investments as of fiscal 2021. There were $10.05M in debt and $74.42M in liabilities at the time. Its Book Value Per Share was $9.31, while its Total Shareholder’s Equity was $504.93M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 1 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VNDA is Buy with a score of 0.00. A total of 0 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles